-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
December 01, 2012 - In 2012, it is
expected to be the fourth most commonly diagnosed cancer (after prostate, breast, and … cancer and aid in determination of
prognosis in breast cancer.”6 Using GEP tests could improve the … Given the current role of GEP testing in patients with breast cancer, questions formulated in a
report … for the AHRQ on GEP testing in patients with breast cancer11 were used to inform this
Technical Brief … A breast cancer prognostic signature
predicts clinical outcomes in multiple tumor
types.
-
effectivehealthcare.ahrq.gov/products/health-literacy/research-protocol
January 22, 2010 - "Predictors of pessimistic breast cancer risk perceptions in a primary care population." … "Black-white differences in risk perceptions of breast cancer survival and screening mammography benefit … "Latina patient perspectives about informed treatment decision making for breast cancer." … "Retention and use of breast cancer recurrence risk information from genomic tests: the role of health … "Agreement between scales in the measurement of breast cancer risk perceptions."
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-literacy_research-protocol.pdf
January 22, 2010 - Predictors of pessimistic breast cancer risk
perceptions in a primary care population. … Black-white differences in risk perceptions of breast cancer
survival and screening mammography benefit … Latina patient perspectives about informed treatment
decision making for breast cancer. … Retention and use of breast cancer recurrence risk
information from genomic tests: the role of health … Agreement between scales in the measurement of
breast cancer risk perceptions.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - In addition, estrogen/progestin was associated
with an increased risk of invasive breast cancer. … harms
varied by a long list of patient characteristics.44-47
Though results suggested that risk of breast … Continued
breast cancer risk reduction in postmenopausal women
treated with raloxifene: 4-year results … Breast
Cancer Res Treat. 2001 Jan;65(2):125-34.
PMID: 11261828.
29. … Continuing outcomes relevant to Evista: breast cancer
incidence in postmenopausal osteoporotic women
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - In addition, estrogen/progestin was associated
with an increased risk of invasive breast cancer. … harms
varied by a long list of patient characteristics.44-47
Though results suggested that risk of breast … Continued
breast cancer risk reduction in postmenopausal women
treated with raloxifene: 4-year results … Breast
Cancer Res Treat. 2001 Jan;65(2):125-34.
PMID: 11261828.
29. … Continuing outcomes relevant to Evista: breast cancer
incidence in postmenopausal osteoporotic women
-
effectivehealthcare.ahrq.gov/products/safety-emerging-methods/executive
September 25, 2007 - Treatment Effect Estimates from Risk-Adjustment and Instrumental Variable Methods: Surgery for Early-Stage Breast
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-3rdplace_tympanic.pdf
January 26, 2013 - Bottle-fed vs. breast-fed
2. Passive cigarette smoking exposure
3.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - We acknowledge that not all trials
included a breast fed group for
benchmarking and that we did not … Again, we acknowledge that not all trials
included a breast fed group for
benchmarking and that we … Note: Breast-feeding Danish women were evaluated
for the impact of supplementation during the first … In children with a FADS genotype linked to
a low endogenous LC-PUFA synthesis, breast-
feeding supplying … Therefore, it is
recommended that women who are pregnant or
breast-feeding consume at least 8 and up
-
effectivehealthcare.ahrq.gov/health-topics/breastfeeding/
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
September 01, 2011 - outcomes tables, such as those included below from the review of
Medications to Reduce Risk of Primary Breast … Placebo
Invasive breast cancer No difference 7 (4,12) † +++
9 (4, 14)
+++
10 (3, 17)
++
Estrogen … Comparative Effectiveness of Medications
to Reduce Risk of Primary Breast Cancer in
Women.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
June 16, 2008 - Clinical Cancer Research 2004;10(5):1764-72.
15014030
Breast
Bush DA, Slater JD, Garberoglio C, … A technique of partial breast irradiation utilizing
proton beam radiotherapy: comparison with conformal … Accelerated partial-breast irradiation using proton
beams: initial clinical experience. … Neutron versus photon
radiotherapy for local control in inoperable breast cancer. … Accelerated partial breast
irradiation using proton beams: Initial dosimetric experience.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-utilization-seniors_research.pdf
June 01, 2012 - heart
disease.6 Cancer is indicated if one or more of the following cancers are
classified: female breast … Part B, fee for service coverage, survived six months.
** Dual / Nondual monthly status changes.
† Breast … Part B, fee for service coverage, survived six months.
** Dual / Nondual monthly status changes.
† Breast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
July 01, 2012 - of the use of non-invasive imaging in addition to standard workup after recall
for evaluation of a breast … Impact of Gene Expression Profiling
Tests on Breast Cancer Outcomes. … Comparative Effectiveness of Core-Needle
and Open Surgical Biopsy for the Diagnosis of
Breast Lesions … Noninvasive Diagnostic Tests for Breast
Abnormalities: Update of a 2006 Review.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/omega-3-maternity_research-protocol.pdf
May 18, 2015 - from fish and other marine sources, some were from dietary supplements,
some were indirect (through breast … is the influence of maternal intakes of n-3 fatty acids or the n-3 fatty
acid content of maternal breast … -3 FA) or n-3 FA-supplemented infant formula or
intakes of n-3 FA from sources other than maternal breast … fatty acids was
assessed during pregnancy
§ Children whose exposure to n-3 fatty acids (through breast … n-3 fatty acids from foods if concentrations are quantified
in food frequency questionnaires
§ Breast
-
effectivehealthcare.ahrq.gov/health-topics/womens-health-checkup
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
February 01, 2017 - 26, all
histologies
89Sr with dendritic
cell vaccine
40 0 NR NR 58% at 36 mo
Yamada,
201214
16, breast … Concurrent use of Sr-89
chloride with zoledronic acid is safe and effective for breast cancer
patients … Bone-related complications
and quality of life in advanced breast cancer: Results from a
randomized phase … versus zoledronic acid in the treatment of bone
metastases in patients with advanced cancer (excluding breast … Denosumab compared with
zoledronic acid for the treatment of bone metastases in patients with
advanced breast
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/pico-populations-breastfeeding-infants-6-months-or-less-with-ankyloglossia-interventions-frenotomy-frenectomy-or-frenulotomy-comparators-breastfeeding-management-without-surgical-intervention-outcomess-successful-exclusive-br
March 14, 2013 - Breastfeeding exclusively at the breast is associated with decreased risk of obesity.
-
effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
January 01, 2007 - Effect
Estimates from Risk-Adjustment and Instrumental Variable Methods: Surgery for Early-
Stage Breast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
January 01, 2012 - A well-known example
is the use of tamoxifen for the prevention of breast cancer. … They then estimated, for each outcome and based on the Breast Cancer Prevention Trial, the
expected … Weighing the risks and benefits of tamoxifen
treatment for preventing breast cancer. … Tamoxifen for the prevention of breast cancer:
current status of the National Surgical Adjuvant
Breast … The International Breast
Cancer Study Group. Cancer Treat Rev. 1993; 19
Suppl A:73-84.
58.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - death (by any cause besides heart
attack) prevents incident heart attack from occurring; in a study of breast … cancer, preventive
double mastectomy likewise may be considered a competing risk for breast cancer. … risks can lead to missing data in certain settings; sometimes a study may be interested in the risk
of breast … beliefs about their personal risks
3
Managing Missing Data in Patient Registries
of developing breast … In such a setting, the breast
cancer status that these women would have had, had they not gotten a mastectomy